Valuation dashboard for Compugen Ltd. (CGEN) with P/E 6.42, P/B 2.57, EV/EBITDA 6.74 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe.
Analysis Summary
Compugen Ltd. reported revenue of $72.8M in the most recent fiscal year, growing at a 5-year CAGR of 105.2%.
Trailing-twelve-month margins: gross margin 86.9%, operating margin 40.9%, net margin 47.6%.
At the current price of $2.41, CGEN trades at a P/E of 6.42 and an ROE of 42.57%. Market capitalisation stands at $228M.
Balance sheet quality for CGEN: current ratio of 6.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 6.42 |
| Price / Book | 2.57 |
| EV / EBITDA | 6.74 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CGEN | Compugen Ltd. | $228M | 6.42 | 2.57 | 42.6% |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $2.41 |
| Market Cap | $228M |
| Exchange | NASDAQ |
| Country | IL |
Profitability
| Return on Equity | 42.57% |
| Return on Invested Capital | 26.00% |
| Return on Assets | 25.43% |
| Gross Margin | 86.89% |
| Operating Margin | 40.94% |
| Net Margin | 47.55% |
Related companies: CRBP · CRDF · CYBN · IPHA · MIST · MOLN · NVCT
Explore sector: Healthcare · Biotechnology
More sections of CGEN: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks